Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1970 Dec;49(12):2237–2245. doi: 10.1172/JCI106442

Effects of glucagon on adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine

Arthur E Broadus 1,2, Neil I Kaminsky 1,2, Robert C Northcutt 1,2, Joel G Hardman 1,2, Earl W Sutherland 1,2, Grant W Liddle 1,2
PMCID: PMC322724  PMID: 5480850

Abstract

Glucagon, infused intravenously into fasting, well-hydrated, normal men in doses of 25-200 ng/kg per min, induced up to 30-fold increases in both plasma and urinary cyclic AMP. Cyclic GMP levels were unaffected by glucagon. Simultaneous cyclic AMP and inulin clearance studies demonstrated that the glucagon-induced increase in urinary cyclic AMP was entirely due to glomerular filtration of the elevated plasma levels of the nucleotide.

The cyclic AMP response to glucagon was not mediated by parathyroid hormone or epinephrine, and trypsintreated glucagon was completely inactive.

The perfused rat liver released cyclic AMP into the perfusate in response to glucagon, indicating that the liver is a possible source of the cyclic AMP entering the extracellular fluids in response to glucagon in vivo.

Full text

PDF
2237

Images in this article

2239Image
on p.2239
2239Image
on p.2239
2242Image
on p.2242
2243Image
on p.2243
2244Image
on p.2244

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHMAN D. F., LIPTON R., MELICOW M. M., PRICE T. D. Isolation of adenosine 3', 5'-monophosphate and guanosine 3', 5'-monophosphate from rat urine. Biochem Biophys Res Commun. 1963 May 22;11:330–334. doi: 10.1016/0006-291x(63)90566-7. [DOI] [PubMed] [Google Scholar]
  2. Avioli L. V., Birge S. J., Scott S., Shieber W. Role of the thyroid gland during glucagon-induced hypocalcemia in the dog. Am J Physiol. 1969 Apr;216(4):939–945. doi: 10.1152/ajplegacy.1969.216.4.939. [DOI] [PubMed] [Google Scholar]
  3. BERTHET J., RALL T. W., SUTHERLAND E. W. The relationship of epinephrine and glucagon to liver phosphorylase. IV. Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. J Biol Chem. 1957 Jan;224(1):463–475. [PubMed] [Google Scholar]
  4. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  5. Barkley D. S. Adenosine-3',5'-phosphate: identification as acrasin in a species of cellular slime mold. Science. 1969 Sep 12;165(3898):1133–1134. doi: 10.1126/science.165.3898.1133. [DOI] [PubMed] [Google Scholar]
  6. Birge S. J., Avioli L. V. Glucagon-induced hypocalcemia in man. J Clin Endocrinol Metab. 1969 Feb;29(2):213–218. doi: 10.1210/jcem-29-2-213. [DOI] [PubMed] [Google Scholar]
  7. Broadus A. E., Kaminsky N. I., Hardman J. G., Sutherland E. W., Liddle G. W. Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. J Clin Invest. 1970 Dec;49(12):2222–2236. doi: 10.1172/JCI106441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Butcher R. W., Baird C. E., Sutherland E. W. Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells. J Biol Chem. 1968 Apr 25;243(8):1705–1712. [PubMed] [Google Scholar]
  9. Butcher R. W., Ho R. J., Meng H. C., Sutherland E. W. Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine. J Biol Chem. 1965 Nov;240(11):4515–4523. [PubMed] [Google Scholar]
  10. Chase L. R., Aurbach G. D. Parathyroid function and the renal excretion of 3'5'-adenylic acid. Proc Natl Acad Sci U S A. 1967 Aug;58(2):518–525. doi: 10.1073/pnas.58.2.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chase L. R., Aurbach G. D. Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science. 1968 Feb 2;159(3814):545–547. doi: 10.1126/science.159.3814.545. [DOI] [PubMed] [Google Scholar]
  12. Chase L. R., Melson G. L., Aurbach G. D. Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest. 1969 Oct;48(10):1832–1844. doi: 10.1172/JCI106149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Crofford O. B. The uptake and inactivation of native insulin by isolated fat cells. J Biol Chem. 1968 Jan 25;243(2):362–369. [PubMed] [Google Scholar]
  14. DAVOREN P. R., SUTHERLAND E. W. THE EFFECT OF L-EPINEPHRINE AND OTHER AGENTS ON THE SYNTHESIS AND RELEASE OF ADENOSINE 3',5'-PHOSPHATE BY WHOLE PIGEON ERYTHROCYTES. J Biol Chem. 1963 Sep;238:3009–3015. [PubMed] [Google Scholar]
  15. Exton J. H., Park C. R. Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats. J Biol Chem. 1967 Jun 10;242(11):2622–2636. [PubMed] [Google Scholar]
  16. Exton J. H., Park C. R. The role of cyclic AMP in the control of liver metabolism. Adv Enzyme Regul. 1968;6:391–407. doi: 10.1016/0065-2571(68)90024-1. [DOI] [PubMed] [Google Scholar]
  17. FLODING I., VON EULER U. S. Diagnosis of pheochromocytoma by fluorimetric estimation of adrenaline and noradrenaline in urine. Scand J Clin Lab Invest. 1956;8(4):288–295. doi: 10.3109/00365515609049286. [DOI] [PubMed] [Google Scholar]
  18. Foà P. P. Glucagon. Ergeb Physiol. 1968;60:141–219. doi: 10.1007/BFb0107253. [DOI] [PubMed] [Google Scholar]
  19. Hardman J. G., Davis J. W., Sutherland E. W. Effects of some hormonal and other factors on the excretion of guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate in rat urine. J Biol Chem. 1969 Dec 10;244(23):6354–6362. [PubMed] [Google Scholar]
  20. Hardman J. G., Davis J. W., Sutherland E. W. Measurement of guanosine 3',5'-monophosphate and other cyclic nucleotides. Variations in urinary excretion with hormonal state of the rat. J Biol Chem. 1966 Oct 25;241(20):4812–4815. [PubMed] [Google Scholar]
  21. Kakiuchi S., Rall T. W. The influence of chemical agents on the accumulation of adenosine 3',5'-Phosphate in slices of rabbit cerebellum. Mol Pharmacol. 1968 Jul;4(4):367–378. [PubMed] [Google Scholar]
  22. Kaminsky N. I., Broadus A. E., Hardman J. G., Jones D. J., Jr, Ball J. H., Sutherland E. W., Liddle G. W. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest. 1970 Dec;49(12):2387–2395. doi: 10.1172/JCI106458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Konijn T. M., Van De Meene J. G., Bonner J. T., Barkley D. S. The acrasin activity of adenosine-3',5'-cyclic phosphate. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1152–1154. doi: 10.1073/pnas.58.3.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kuschke H. J., Klusmann H., Schölkens B. Untersuchungen über die Wirkung von Glucagon auf das sympatho-adrenale System des Menschen. Klin Wochenschr. 1966 Nov 15;44(22):1297–1300. doi: 10.1007/BF01716601. [DOI] [PubMed] [Google Scholar]
  25. LOWRY O. H., PASSONNEAU J. V., HASSELBERGER F. X., SCHULZ D. W. EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. J Biol Chem. 1964 Jan;239:18–30. [PubMed] [Google Scholar]
  26. Lefebvre P. J., Cession-Fossion A. M., Luyckx A. S., Lecomte J. L., Van Cauwenberge H. S. Interrelationships glucagon-adrenergic system in experimental and clinical conditions. Arch Int Pharmacodyn Ther. 1968 Apr;172(2):393–404. [PubMed] [Google Scholar]
  27. MAKMAN M. H., SUTHERLAND E. W., Jr USE OF LIVER ADENYL CYCLASE FOR ASSAY OF GLUCAGON IN HUMAN GASTRO-INTESTINAL TRACT AND PANCREAS. Endocrinology. 1964 Jul;75:127–134. doi: 10.1210/endo-75-1-127. [DOI] [PubMed] [Google Scholar]
  28. MAKMAN R. S., SUTHERLAND E. W. ADENOSINE 3',5'-PHOSPHATE IN ESCHERICHIA COLI. J Biol Chem. 1965 Mar;240:1309–1314. [PubMed] [Google Scholar]
  29. MERTZ D. P. [On the diuretic and saluretic effect of glucagon in man]. Z Gesamte Exp Med. 1963;136:331–337. [PubMed] [Google Scholar]
  30. Murad F., Vaughan M. Effect of glucagon on rat heart adenyl cyclase. Biochem Pharmacol. 1969 May;18(5):1053–1059. doi: 10.1016/0006-2952(69)90109-9. [DOI] [PubMed] [Google Scholar]
  31. OKABAYASHI T., YOSHIMOTO A., IDE M. OCCURRENCE OF NUCLEOTIDES IN CULTURE FLUIDS OF MICROORGANISMS. V. EXCRETION OF ADENOSINE CYCLIC 3',5'-PHOSPHATE BY BREVIBACTERIUM LIQUEFACIENS SP. N. J Bacteriol. 1963 Nov;86:930–936. doi: 10.1128/jb.86.5.930-936.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Price T. D., Ashman D. F., Melicow M. M. Organophosphates of urine, including adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. Biochim Biophys Acta. 1967 May 30;138(3):452–465. doi: 10.1016/0005-2787(67)90542-4. [DOI] [PubMed] [Google Scholar]
  33. Robison G. A., Butcher R. W., Sutherland E. W. Cyclic AMP. Annu Rev Biochem. 1968;37:149–174. doi: 10.1146/annurev.bi.37.070168.001053. [DOI] [PubMed] [Google Scholar]
  34. SCIAN L. F., WESTERMANN C. D., VERDESCA A. S., HILTON J. G. Adrenocortical and medullary effects of glucagon. Am J Physiol. 1960 Nov;199:867–870. doi: 10.1152/ajplegacy.1960.199.5.867. [DOI] [PubMed] [Google Scholar]
  35. Sheps S. G., Maher F. T. Histamine and glucagon tests in diagnosis of pheochromocytoma. JAMA. 1968 Sep 23;205(13):895–899. [PubMed] [Google Scholar]
  36. Sussman K. E., Vaughan G. D. Insulin release after ACTH, glucagon and adenosine-3'-5'-phosphate (cyclic AMP) in the perfused isolated rat pancreas. Diabetes. 1967 Jul;16(7):449–454. doi: 10.2337/diab.16.7.449. [DOI] [PubMed] [Google Scholar]
  37. WOLLENBERGER A., RISTAU O., SCHOFFA G. [A simple technic for extremely rapid freezing of large pieces of tissue]. Pflugers Arch Gesamte Physiol Menschen Tiere. 1960;270:399–412. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES